No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease.
Gastroenterology
; 152(4): 787-798.e2, 2017 03.
Article
in En
| MEDLINE
| ID: mdl-27864127
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Gastrointestinal Agents
/
Celiac Disease
/
Duodenum
/
Intestinal Mucosa
Type of study:
Clinical_trials
/
Diagnostic_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Gastroenterology
Year:
2017
Document type:
Article
Country of publication:
United States